Skip to main content
. 2017 Mar 1;3(1):41–50. doi: 10.1016/j.cdtm.2017.01.005

Fig. 3.

Fig. 3

Forest plot showing the pooled effect of disease-free survival with ART compared to that with cALND for the patients with SLN-positive breast cancer. HR: hazard ratio; CI: confidence interval; ART: axillary radiotherapy; cALND: completion axillary lymph node dissection.